These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12894224)

  • 61. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
    Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
    Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
    Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
    [TBL] [Abstract][Full Text] [Related]  

  • 63. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression.
    Zeng YX; Somasundaram K; el-Deiry WS
    Nat Genet; 1997 Jan; 15(1):78-82. PubMed ID: 8988173
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression.
    Yang X; He Z; Xin B; Cao L
    Oncogene; 2000 Apr; 19(16):2002-13. PubMed ID: 10803461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells.
    Davis JN; Singh B; Bhuiyan M; Sarkar FH
    Nutr Cancer; 1998; 32(3):123-31. PubMed ID: 10050261
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of cell proliferation by the interferon-inducible 204 gene, a member of the Ifi 200 cluster.
    Lembo M; Sacchi C; Zappador C; Bellomo G; Gaboli M; Pandolfi PP; Gariglio M; Landolfo S
    Oncogene; 1998 Mar; 16(12):1543-51. PubMed ID: 9569021
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The interferon-inducible autoantigen, IFI 16: localization to the nucleolus and identification of a DNA-binding domain.
    Dawson MJ; Trapani JA
    Biochem Biophys Res Commun; 1995 Sep; 214(1):152-62. PubMed ID: 7545391
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha.
    Geng Y; Choubey D
    J Biol Regul Homeost Agents; 2000; 14(4):263-8. PubMed ID: 11215814
    [TBL] [Abstract][Full Text] [Related]  

  • 69. p16 INK4a can initiate an autonomous senescence program.
    Dai CY; Enders GH
    Oncogene; 2000 Mar; 19(13):1613-22. PubMed ID: 10763818
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dynamics of notch expression during murine prostate development and tumorigenesis.
    Shou J; Ross S; Koeppen H; de Sauvage FJ; Gao WQ
    Cancer Res; 2001 Oct; 61(19):7291-7. PubMed ID: 11585768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. p53-Independent tumorigenic progression of human prostate cells.
    Ramsamooj P; Kuettel M; Dritschilo A; Jung M
    Radiat Oncol Investig; 1997; 5(6):269-74. PubMed ID: 9436243
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
    Yin H; Lowery M; Glass J
    Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1.
    Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD
    Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
    Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
    Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.
    Tran CP; Lin C; Yamashiro J; Reiter RE
    Mol Cancer Res; 2002 Dec; 1(2):113-21. PubMed ID: 12496358
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer.
    Chen YC; Zhang XW; Niu XH; Xin DQ; Zhao WP; Na YQ; Mao ZB
    Oncogene; 2010 May; 29(21):3067-78. PubMed ID: 20383199
    [TBL] [Abstract][Full Text] [Related]  

  • 77. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
    Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
    Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin.
    Wang Y; Blandino G; Givol D
    Oncogene; 1999 Apr; 18(16):2643-9. PubMed ID: 10353608
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.
    Watabe T; Lin M; Ide H; Donjacour AA; Cunha GR; Witte ON; Reiter RE
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):401-6. PubMed ID: 11752398
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cellular senescence in the pathogenesis of benign prostatic hyperplasia.
    Castro P; Giri D; Lamb D; Ittmann M
    Prostate; 2003 Apr; 55(1):30-8. PubMed ID: 12640658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.